SCHEMBL7482010

SCHEMBL7482010

CCSCCNc1nnc(NC(=O)/C=C/c2ccccc2)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
RAB9A P51151 6/20 0.48
HPGD P15428 4/20 0.48
NPSR1 Q6W5P4 3/20 0.48
LMNA P02545 1/20 0.48
KMT2A Q03164 4/20 0.48
MEN1 O00255 2/20 0.48
METAP2 P50579 1/20 0.48
FSCN1 Q16658 1/20 0.47
NPC1 O15118 5/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KDM4E B2RXH2 3/20 0.46
TP53 P04637 1/20 0.46
NFKB1 P19838 1/20 0.46
NFKB2 Q00653 1/20 0.46
RELA Q04206 1/20 0.46
POLB P06746 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
GLS O94925 1/20 0.44
PARP1 P09874 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7482017 1.00 ALDH1A1 (0.48) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7487562 0.85 KMT2A (0.52) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7487555 0.85 KMT2A (0.52) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7479601 0.85 MEN1 (0.49) ALDH1A1RAB9AHPGDLMNAKMT2A
SCHEMBL7479605 0.85 MEN1 (0.49) ALDH1A1RAB9AHPGDLMNAKMT2A
SCHEMBL7487114 0.83 EGFR (0.60) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7487107 0.83 EGFR (0.60) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7480810 0.82 MMP1 (0.55) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7480813 0.82 MMP1 (0.55) ALDH1A1RAB9AHPGDNPSR1LMNA
SCHEMBL7488537 0.82 FSCN1 (0.52) ALDH1A1RAB9AHPGDNPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP claimed
US-6150385-A VIRICIDE WITH ACTIVITY AGAINST CYTOMEGALO VIRUS (CMV), HERPES VIRUS INCLUDING VARICELLA ZOSTER VIRUS, THE EPSTEIN-BARR VIRUS, THE HERPES SIMPLEX VIRUS, AND THE HUMAN HERPES VIRUS TYPE 8 (HHV-8) PHARMACIA & UPJOHN COMPANY (US) 2000-11-21 US claimed
EP-1064273-B1 1,3,4-THIADIAZOLES USEFUL FOR THE TREATMENT OF CMV INFECTIONS UPJOHN CO (US) 2002-12-18 EP disclosed